APOC1 and type 1 diabetes mellitus: The elucidation of the mechanisms underlying the loss of the capacity of apoC1 to inhibit CETP in people with T1D is of major interest because the restoration of apoC1 functionality might help to counteract the deleterious effects of increased CETP activity on the plasma lipoprotein profile in this high cardiovascular risk population.